WO2023185606A1 - Implantable cardiac pacemaker, program control apparatus, and cardiac pacing system - Google Patents

Implantable cardiac pacemaker, program control apparatus, and cardiac pacing system Download PDF

Info

Publication number
WO2023185606A1
WO2023185606A1 PCT/CN2023/083250 CN2023083250W WO2023185606A1 WO 2023185606 A1 WO2023185606 A1 WO 2023185606A1 CN 2023083250 W CN2023083250 W CN 2023083250W WO 2023185606 A1 WO2023185606 A1 WO 2023185606A1
Authority
WO
WIPO (PCT)
Prior art keywords
acoustic impedance
ultrasonic
film
variable acoustic
cardiac pacemaker
Prior art date
Application number
PCT/CN2023/083250
Other languages
French (fr)
Chinese (zh)
Inventor
张建锋
Original Assignee
创领心律管理医疗器械(上海)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 创领心律管理医疗器械(上海)有限公司 filed Critical 创领心律管理医疗器械(上海)有限公司
Publication of WO2023185606A1 publication Critical patent/WO2023185606A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37217Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/37512Pacemakers

Definitions

  • the present invention relates to the medical field, and in particular to an implantable cardiac pacemaker, a program-controlled device and a cardiac pacing system.
  • the implantable pacemaker is a major contribution of modern biomedical engineering to centuries.
  • the implantable pacemaker allows patients with severe arrhythmias who were ineffective in drug treatment in the past to be treated.
  • the use of pacemakers has successfully treated chronic arrhythmia. While arrhythmias have saved the lives of thousands of patients, pacemakers are also used in tachyarrhythmias and non-cardiac diseases, such as the prevention of paroxysmal atrial tachyarrhythmia, carotid sinus syncope, and biventricular synchrony. Treatment of drug-refractory congestive heart failure has significantly reduced cardiovascular disease mortality.
  • pacemakers With the development of technology and applications, modern implantable pacemakers need to have the function of duplex communication with the outside world, such as program control and wireless telemetry of the pacemaker implanted in the body by external equipment. At the same time, pacemakers are also improving in terms of lightweighting and miniaturization.
  • the implantable leadless pacemaker has been developed, which has the advantages of reducing complications, less trauma, easy implantation, and compatible with MRI. , is the future development direction of pacing technology.
  • HBC Human Body Communication
  • HBC Human Body Communication
  • the present invention provides an implantable cardiac pacemaker, a program-controlled device and a cardiac pacing system.
  • the present invention provides an implantable cardiac pacemaker, which includes a variable acoustic impedance module and a signal processing module.
  • the variable acoustic impedance module is used to sense ultrasonic signals and convert the ultrasonic signals into corresponding electrical signals. Sent to the signal processing module, the acoustic impedance of the variable acoustic impedance module can be changed under the control of the signal processing module, and a corresponding ultrasonic reflection signal is generated; the ultrasonic signal and the ultrasonic reflection signal are used for The implantable pacemaker communicates with the outside world.
  • the variable acoustic impedance module includes a variable acoustic impedance film electrically connected to the signal processing module; the acoustic impedance of the variable acoustic impedance film varies according to different signals from the signal processing module, and the variable acoustic impedance film The acoustic impedance of the impedance film generates a corresponding ultrasonic reflection signal according to the signal of the signal processing module.
  • variable acoustic impedance module also includes a piezoelectric film electrically connected to the signal processing module.
  • the piezoelectric film is used to sense the ultrasonic signal and convert the ultrasonic signal into a corresponding electrical signal. and then sent to the signal processing module.
  • the implantable cardiac pacemaker further includes a shell, the shell is set outside the variable acoustic impedance module and the signal processing module, the variable acoustic impedance module further includes a backing, the A backing is provided on the inner surface of the housing, and the piezoelectric film and the variable acoustic impedance film are arranged in zones on the backing.
  • variable acoustic impedance module further includes a first sound absorbing film and a second sound absorbing film, the first sound absorbing film is located between the piezoelectric film and the variable acoustic impedance film, and the third sound absorbing film is located between the piezoelectric film and the variable acoustic impedance film.
  • Two sound-absorbing films are located on the side of the variable acoustic impedance film away from the piezoelectric film.
  • the piezoelectric film, the variable acoustic impedance film, the first sound-absorbing film and the second sound-absorbing film are all annular structures, and their axes are parallel.
  • the width of the first sound-absorbing film is different from the width of the second sound-absorbing film, and both are different from the width of the variable acoustic impedance film.
  • the signal processing module changes the acoustic impedance of the variable acoustic impedance module by energizing or de-energizing the variable acoustic impedance film.
  • the signal processing module includes a processor, an ADC unit and a DAC unit; the ADC unit is used to convert the electrical signal sent by the variable acoustic impedance module into a digital signal and send it to the processor;
  • the DAC unit is used to convert the signal sent by the processor for changing the acoustic impedance into an analog signal and send it to the variable acoustic impedance module.
  • the variable acoustic impedance module adjusts according to the analog signal sent by the DAC unit. Acoustic impedance.
  • the implantable cardiac pacemaker is a leadless pacemaker.
  • the present invention provides a program-controlled device.
  • the program-controlled device includes a program-controlled instrument host and an ultrasonic program-controlled head; the ultrasonic program-controlled head is used to send ultrasonic signals and sense ultrasonic reflection signals; the program-controlled instrument host is controlled by the ultrasonic program
  • the ultrasonic signal emitted by the head transmits data to the implanted cardiac pacemaker, and the acoustic impedance state of the implanted cardiac pacemaker is obtained through the ultrasonic reflection signal sensed by the ultrasonic programming control head. According to the acoustic impedance state Changes to acquire data from the implantable pacemaker.
  • the present invention provides a cardiac pacing system, which includes the above-mentioned implantable cardiac pacemaker and a program-controlled device.
  • the implantable cardiac pacemaker includes a variable acoustic impedance module and a signal processing module.
  • the variable acoustic impedance module is used to sense ultrasonic signals, convert the ultrasonic signals into corresponding electrical signals and send them to the Signal processing module, the acoustic impedance of the variable acoustic impedance module can be changed under the control of the signal processing module and generate a corresponding ultrasonic reflection signal; the ultrasonic signal and the ultrasonic reflection signal are used for the implantable heart
  • the pacemaker communicates with the outside world.
  • the implantable cardiac pacemaker uses a variable acoustic impedance module to sense the ultrasonic signal, and the ultrasonic signal can be used to obtain data from the outside.
  • the corresponding Ultrasonic reflection signal which can be used to send data to the outside.
  • ultrasonic signals and ultrasonic reflection signals are used for communication instead of using human tissue as the medium for current conduction, it is not affected by the cardiac cycle and can be used at any time as needed.
  • External ultrasound sending and receiving equipment initiates communication with high real-time performance.
  • the implantable cardiac pacemaker communicates based on the change of acoustic impedance of the implanted end under single-source ultrasound. The communication process has low requirements on the circuit structure and battery capacity of the implanted end, which is convenient for the implanted cardiac pacemaker. Miniaturization, such as leadless pacemakers.
  • the ultrasonic program-controlled head can send ultrasonic signals and sense ultrasonic reflections.
  • the program controller host transmits data to the implanted cardiac pacemaker through the ultrasonic signal, and obtains the acoustic impedance state of the implanted cardiac pacemaker through the ultrasonic reflection signal sensed by the ultrasonic program control head. , the data of the implantable cardiac pacemaker is obtained according to the change of the acoustic impedance state. Since ultrasonic signals and ultrasonic reflection signals are used for communication instead of using human tissue as the medium for current conduction, it is not affected by the cardiac cycle. Impact, communication can be initiated by external ultrasonic sending and receiving equipment at any time as needed, with high real-time performance.
  • the cardiac pacing system provided by the present invention includes the above-mentioned implantable cardiac pacemaker and a program-controlled device, which can realize real-time communication with external equipment, and the communication process has low requirements on the circuit structure and battery capacity of the implanted end, which is convenient for implantation. Miniaturization of pacemakers.
  • Figure 1 is a schematic diagram of a cardiac pacing system according to an embodiment of the present invention.
  • Figure 2 is a schematic diagram of an implantable cardiac pacemaker according to an embodiment of the present invention.
  • FIG. 3 is a schematic diagram of a partial area of the implantable cardiac pacemaker shown in FIG. 2 .
  • Figure 4 is a flow chart of communication between an implantable cardiac pacemaker and a programmable device according to an embodiment of the present invention.
  • FIG. 5 is a schematic diagram of a communication frame used for data transmission between the implantable cardiac pacemaker 100 and the program control device 200 according to an embodiment of the present invention.
  • FIG. 1 is a schematic diagram of a cardiac pacing system according to an embodiment of the present invention.
  • an embodiment of the present invention relates to an implantable cardiac pacemaker 100, a program-controlled device 200 and a cardiac pacing system.
  • the cardiac pacing system includes the implanted cardiac pacemaker 100 and a program-controlled device.
  • Device 200 when the cardiac pacing system is working, the implantable cardiac pacemaker 100 is implanted in the body, the program control device 200 is located outside the body, and the implantable cardiac pacemaker 100 and the program control device 200 can use ultrasound signals and Ultrasonic reflection signals communicate to meet the needs of program control and telemetry. It can be used in situations such as doctors or patients modifying the parameters of implanted medical devices through in vitro program settings, or reading data stored by implanted medical devices during work. . Specific instructions are as follows.
  • the implantable cardiac pacemaker 100 includes a variable acoustic impedance module 110 and a signal processing module (not shown in Figure 1) provided in the housing; the variable acoustic impedance module 110 is used to sense ultrasound signals, and Convert the ultrasonic signal into a corresponding electrical signal and send it to the signal processing module; the acoustic impedance of the variable acoustic impedance module 110 can be changed under the control of the signal processing module and generate a corresponding ultrasonic reflection signal; The ultrasonic signal and the ultrasonic reflection signal are used for the implantable cardiac pacemaker 100 to communicate with the outside.
  • the implantable cardiac pacemaker 100 uses the variable acoustic impedance module 110 to sense ultrasonic signals, and the ultrasonic signals can be used to obtain data from the outside.
  • the ultrasonic signals can be used to obtain data from the outside.
  • by changing the acoustic impedance of the variable acoustic impedance module 110 it generates corresponding ultrasonic signals.
  • the ultrasonic reflection signal changes with the change of the acoustic impedance of the variable acoustic impedance module 110, and the ultrasonic reflection signal can be used to transmit data to the outside.
  • FIG. 2 is a schematic diagram of an implantable cardiac pacemaker according to an embodiment of the present invention.
  • FIG. 3 is a schematic diagram of a partial area of the implantable cardiac pacemaker shown in FIG. 2 .
  • the variable acoustic impedance module 110 in the implantable cardiac pacemaker 100 may include a variable acoustic impedance film 111 , and the variable acoustic impedance film 111 is consistent with the variable acoustic impedance module 110 .
  • the signal processing module is electrically connected.
  • the acoustic impedance of the variable acoustic impedance film 111 is different according to different signals of the signal processing module.
  • variable acoustic impedance of the variable acoustic impedance film 111 generates a corresponding ultrasonic reflection signal according to the signal of the signal processing module. , so that the implantable cardiac pacemaker 100 transmits data to the outside.
  • the variable acoustic impedance module 110 also includes a piezoelectric film 112 electrically connected to the signal processing module. The piezoelectric film 112 is used to sense ultrasonic signals and convert the sensed ultrasonic signals into corresponding electrical signals. Send later to the signal processing module.
  • Both the variable acoustic impedance film 111 and the piezoelectric film 112 in the variable acoustic impedance module 110 may include a piezoelectric layer, a first electrode disposed on one side surface of the piezoelectric layer, and a first electrode disposed on the other side surface of the piezoelectric layer.
  • the second electrode, the piezoelectric layer can be made of polyvinylidene fluoride (PVDF), aluminum nitride (AlN), zinc oxide (ZnO), lead zirconate titanate (PZT), lithium niobium oxide (LiNbO3), tantalum oxide Lithium (LiTaO3), or one or more of other piezoelectric materials.
  • the variable acoustic impedance module 110 uses a variable acoustic impedance film 111 to generate an ultrasonic reflection signal, and additionally uses a piezoelectric film 112 to sense the ultrasonic signal, so that the variable acoustic impedance film 11 and the piezoelectric film 112
  • the signal processing processes do not interfere with each other.
  • the signal processing module can send another electrical signal to the variable acoustic impedance film 111 while receiving the electrical signal generated by the piezoelectric film 112 based on the sensed ultrasonic signal, so it can achieve full dual Industrial communications.
  • the present invention is not limited to this.
  • variable acoustic impedance module 110 may not be provided with the piezoelectric film 112 , but may use the variable acoustic impedance film 111 for generating ultrasonic reflection signals to sense the ultrasonic signal, and use the variable acoustic impedance film 111 to generate the ultrasonic reflection signal.
  • the ultrasonic signal is converted into a corresponding electrical signal and then sent to the signal processing module.
  • the process of processing the ultrasonic signal by the variable acoustic impedance film 111 and the process of generating the ultrasonic reflection signal can be performed in a time-sharing manner.
  • the implantable cardiac pacemaker 100 may further include a housing 101 , which is set outside the variable acoustic impedance module 110 and the signal processing module.
  • the variable acoustic impedance module 110 may further include a backing 113 disposed on the inner surface of the housing 101 , and the piezoelectric film 112 and the variable acoustic impedance film 111 are arranged in zones on the backing 113 . Ultrasonic signals from the outside reach the backing 113 and are sensed by the piezoelectric film 112 .
  • the variable acoustic impedance module 110 may further include a first sound-absorbing film 114 and a second sound-absorbing film 115 , which are, for example, located on the inner surface of the backing 113 .
  • the first sound-absorbing film 114 is located between the piezoelectric film 112 and the variable acoustic impedance film 111 to isolate them.
  • the second sound-absorbing film 115 is located on the side of the variable acoustic impedance film 111 away from the piezoelectric film 112 .
  • the first sound-absorbing film 114 and the second sound-absorbing film 115 are used to determine the emission position of the ultrasonic reflection signal, and then find and detect the state of the variable acoustic impedance film 111 based on the emission position.
  • the width direction of the first sound absorbing film 114 and the second sound absorbing film 115 is along the arrangement direction of the piezoelectric film 112 and the variable acoustic impedance film 111 .
  • the first sound-absorbing film 114 can be provided The width of is different from the width of the second sound-absorbing film 115, and both are different from the width of the variable acoustic impedance film 111.
  • the width of the second sound-absorbing film 115 is greater than the width of the variable acoustic impedance film 111, and the width of the first sound-absorbing film 114 is smaller than the width of the variable acoustic impedance film 111, but is not limited thereto.
  • the width of the second sound-absorbing film 115 is smaller than the width of the variable acoustic impedance film 111
  • the width of the first sound-absorbing film 114 is larger than the width of the variable acoustic impedance film 111 .
  • the implanted pacemaker 100 is The housing 101 of the implantable pacemaker 100 can be a cylindrical structure as shown in Figure 2 (for example, a cylindrical structure, the outer surface of the cylindrical structure is a cylindrical surface), and the battery of the implantable pacemaker 100 can be configured within the column structure.
  • the variable acoustic impedance module 110 can be arranged in the column structure using a hollow ring structure, and the hollow can be fed through the electrodes.
  • variable acoustic impedance film 111, first sound-absorbing film 114 and second sound-absorbing film 115 can be connected end to end in the housing 101, that is, they are all arranged in a ring structure.
  • the piezoelectric film 112 The axes of the variable acoustic impedance film 111, the first sound absorbing film 114 and the second sound absorbing film 115 are, for example, parallel.
  • the axis of the annular structure may be arranged parallel to the axis of the housing 101 .
  • the first sound-absorbing film 114 and the second sound-absorbing film 115 form a sound-absorbing ring as shown in FIG. 2 .
  • the ultrasonic signal is sensed by the variable acoustic impedance module 110 from the side of the above-mentioned cylindrical structure.
  • This method does not have high requirements on the orientation of the implantable pacemaker 100 and is not affected by the implantation position.
  • the shapes and positions of the piezoelectric film 112, the variable acoustic impedance film 111, the first sound-absorbing film 114 and the second sound-absorbing film 115 in Figures 2 and 3 are only examples. In other embodiments, Any of them may adopt other shapes and/or positions.
  • the backing 113 may comprise the same material as the housing 101 of the implantable pacemaker 100, such as titanium.
  • the sound-absorbing ring is made of silicon oxide or other materials, for example.
  • FIG 4 is a flow chart of communication between an implantable cardiac pacemaker and a programmable device according to an embodiment of the present invention.
  • the signal processing module in the implantable cardiac pacemaker 100 is denoted as signal processing module 120.
  • the signal processing module 120 may include a processor 121 and an ADC unit 122.
  • the ADC unit 122 is used to convert an electrical signal (eg, an analog signal) sent by the variable acoustic impedance module 110 (eg, sent by the piezoelectric film 112 ) into a digital signal, and send it to the processor 121 .
  • the processor 121 also uses the implantable cardiac pacemaker 100 to control the pacing function. capable processor to save space.
  • the processor 121 may include logically separable software (computer program), hardware, or equivalent components.
  • the processor 121 is, for example, a chip. The specific structure of the processor is not particularly limited in this embodiment.
  • the processor 121 can generate a feedback signal according to the received electrical signal, and can send the data stored or sensed by the implantable pacemaker 100 to the outside.
  • the signal processing module 120 may also include a DAC unit 123, the DAC unit 123 is used to convert the processor
  • the signal (which is a digital signal) sent by 121 for changing the acoustic impedance is converted into an analog signal and sent to the variable acoustic impedance module 110 (specifically sent to the variable acoustic impedance film 111).
  • the variable acoustic impedance module 110 can be configured according to the DAC unit.
  • the analog signal sent by 123 adjusts the acoustic impedance.
  • one electrode (such as the positive electrode, represented by “+”) of the piezoelectric film 112 is connected to the processor 121 through the ADC unit 122 , and the other electrode (such as the negative electrode, represented by “-”) is also connected to the processor 121 Connect to form a loop.
  • One electrode (such as the positive electrode, represented by "+”) of the variable acoustic impedance film 111 is connected to the processor 121 through the DAC unit 123, and the other electrode (such as the negative electrode, represented by "-") is also connected to the processor 121, so as to Form a loop.
  • the ADC unit 122 and the DAC unit 123 may be implemented by different devices, or may be implemented by the same device, which is not particularly limited in this embodiment.
  • the implantable cardiac pacemaker 100 in the embodiment of the present invention uses the variable acoustic impedance module 110 to sense ultrasonic signals, and the ultrasonic signals can be used to obtain data from the outside.
  • the implantable cardiac pacemaker 100 is a leadless pacemaker.
  • the leadless pacemaker does not need to be connected to wires and is small in size.
  • the ultrasonic signals and ultrasonic reflection signals When using the above-mentioned ultrasonic signals and ultrasonic reflection signals to communicate with the outside, it can not only Communication is initiated by the ultrasound transmitting and receiving equipment located outside the body at any time as needed, which is highly real-time and can communicate based on changes in the acoustic impedance of the implanted end under single-source ultrasound without significantly increasing the size of the leadless pacemaker.
  • the requirements for battery capacity are low, and the communication process has low requirements for the circuit structure and battery capacity of the implanted end.
  • Embodiments of the present invention also include a program-controlled device through which a user can set and read parameters and stored data of the above-mentioned implantable pacemaker 100.
  • the program control device 200 includes a program control instrument host 210 and an ultrasonic program control head 220, both of which can be connected via cables. connect.
  • the ultrasonic program control head 220 is used to send ultrasonic signals and sense ultrasonic reflection signals. For example, it can send out ultrasonic signals under the control of the program controller host 210 and can also sense the object (here, a plant) where the emitted ultrasonic signal passes through the target position.
  • the ultrasonic reflection signal obtained after reflection by the variable acoustic impedance module 110 in the implantable cardiac pacemaker 100 can be converted into a corresponding electrical signal and then sent to the program controller host 210.
  • the program controller host 210 transmits data to the implanted cardiac pacemaker through the ultrasonic signal sent by the ultrasonic program control head 220, and obtains the acoustic impedance of the implanted cardiac pacemaker through the ultrasonic reflection signal sensed by the ultrasonic program control head 220. state, and the data of the implantable cardiac pacemaker 100 is obtained according to the change in the acoustic impedance state, that is, the single-source ultrasound mode is used to realize the function of communicating with the implanted cardiac pacemaker.
  • the program controller host 210 may include a control system, a display, an input and output device, etc.
  • the ultrasonic signal and the ultrasonic reflection signal are, for example, pulse signals to facilitate data transmission.
  • the specific structures of the program controller host 210 and the ultrasonic program control head 220 are not particularly limited.
  • the program-controlled device 200 in the embodiment of the present invention uses ultrasonic signals and ultrasonic reflection signals for communication instead of using human tissue as the medium for current conduction. Therefore, it is not affected by the cardiac cycle and can initiate communication at any time by external ultrasonic sending and receiving equipment as needed. , high real-time performance.
  • the cardiac pacing system includes the above-mentioned implantable cardiac pacemaker 100 and a program control device 200 .
  • the data transmission between the implanted cardiac pacemaker 100 and the programming device 200 in the cardiac pacing system may include the following process: when the user needs to program data to the implanted cardiac pacemaker 100
  • the program controller host 210 prepares relevant data and converts the data into ultrasonic signals through the ultrasonic program control head 220.
  • the variable acoustic impedance module 110 senses the ultrasonic signals and their changes, and sends corresponding analog electrical signals to the signal processing module 120.
  • the module 120 converts it into a digital signal through the ADC unit 122 and transmits it to the processor 121, thereby realizing the transmission of data from outside the body to the body, as shown in process A in Figure 4; when it is necessary to read the implanted cardiac pacing
  • the ultrasonic program control head 220 first sends an ultrasonic signal
  • the processor 121 first receives the corresponding instruction through the same path as process A, and sends data to the ultrasonic program control head 220 based on the instruction.
  • the processor 121 sends
  • the digital signal is converted into an analog signal through the DAC unit 123. Under the action of the analog signal, the acoustic impedance of the variable acoustic impedance module 110 changes.
  • the ultrasonic signal sent by the ultrasonic program control head 220 is reflected by the ultrasonic reflection formed by the variable acoustic impedance module 110.
  • the signal changes the ultrasonic program control head 220 senses
  • the changed ultrasonic reflection signal is detected, converted into a corresponding electrical signal, and then returned to the program controller host 210, thereby realizing the transmission of data from the inside to the outside of the body, as shown in process B in Figure 4.
  • the implantable cardiac pacemaker 100 when the implantable cardiac pacemaker 100 sends feedback signals or data to the outside, in order to change the acoustic impedance of the variable acoustic impedance module 110, in one embodiment, the implantable cardiac pacemaker 100
  • the signal processing module inside can control the variable acoustic impedance film 111 to be powered on or off.
  • the variable acoustic impedance film 111 will exhibit different acoustic impedances when powered on or off. Therefore, the operation of turning on and off the power can also
  • the acoustic impedance of variable acoustic impedance module 110 may be varied.
  • the communication data transmitted between the implantable cardiac pacemaker 100 and the programming device 200 is described below by way of example.
  • the program control device 200 when the program control device 200 receives the ultrasonic reflection signal reflected back from the body, when the acoustic impedance of the variable acoustic impedance module 110 in the implantable cardiac pacemaker 100 does not change, the program control device 200 receives the corresponding ultrasonic signal. After reflecting the signal, the corresponding acoustic impedance state is recorded as the first level. When the acoustic impedance of the variable acoustic impedance module 110 changes, the program control device 200 receives the corresponding ultrasonic reflection signal and records the corresponding acoustic impedance state as a second level, which is opposite to the first level.
  • the acoustic impedance state detected from the ultrasonic program control head 220 when the variable acoustic impedance film 111 is not energized can be recorded as 0, and the acoustic impedance state when there is current flowing through it can be recorded as 1.
  • the processor 121 uses the first level as the level of the ultrasonic signal.
  • the processor 121 uses the second level as the level of the ultrasonic signal, and the second level is opposite to the first level. For example, when the above-mentioned piezoelectric film 112 senses the ultrasonic signal emitted by the ultrasonic program control head 220, the processor 121 obtains the voltage change, which is recorded as 1. When no ultrasonic signal is sensed, there is no voltage or no voltage change, which is recorded as 0.
  • the ultrasonic program control head 220 completes the transmission and sensing of ultrasonic signals.
  • the data in the communication process can use pulse signals, and the pulse width can be adjusted according to actual needs.
  • This encoding method only considers whether there are changes in the voltage signal, and does not require high accuracy for the ADC unit 122 and DAC unit 123, which facilitates system design and integration.
  • the present invention is not limited to this. In other embodiments, other communication signal settings may also be used.
  • the data transmitted between the implantable cardiac pacemaker 100 and the program control device 200 is sent periodically, for example.
  • the data transmitted in each communication cycle is called a communication frame.
  • Each communication frame includes a frame header and frame data, which can be initiated by the external programmer host 210 through the ultrasonic program control head 220.
  • communication can be performed through a set sequence.
  • FIG. 5 is a schematic diagram of a communication frame used for data transmission between the implantable cardiac pacemaker 100 and the program control device 200 according to an embodiment of the present invention. Referring to Figure 5, the data segments are numbered for convenience of explanation.
  • Example No. 1 consists of 5-bit binary data and represents the ultrasonic signal sequence sent by the ultrasonic program control head 220.
  • Number 2 is information that changes the acoustic impedance when the processor 121 receives this sequence.
  • the example consists of 3-bit binary data. After sending data No. 1 and No. 2 and after the ultrasonic program control head 220 senses the response data from the processor 121, No. 3 is sent. No. 3 represents which end of this communication transmits the data.
  • 01 represents that the program-controlled device 200 needs to transmit data.
  • 10 represents the implantable pacemaker 100 transmitting data.
  • the frame data includes a data segment 4 that represents the length of the entire frame (8 bits in the example), a data segment 5 that represents a checksum, and a data segment 6 that represents the data to be transmitted in the current communication. If there is no data transmission from the implantable pacemaker 100, a reply of 0xFF (frame data length) can be set to end this communication.
  • 0xFF frame data length
  • the cardiac pacing system is based on single-source ultrasound, and can use the program-controlled device 200 to detect changes in the acoustic impedance of the variable acoustic impedance module 110 in the implantable cardiac pacemaker 100 outside the body.
  • the changes in acoustic impedance can be used as a carrier of information.
  • Passive communication between the implantable cardiac pacemaker 100 and the program-controlled device 200 is realized.
  • the variable acoustic impedance module 110 can sense the ultrasonic signal and convert the ultrasonic signal into an electrical signal, so it can also realize communication from outside the body to the body, that is, it can Enables duplex communication.
  • ultrasonic signals and ultrasonic reflected signals are used for communication instead of using human tissue as the medium for current conduction, it is not affected by the cardiac cycle. Communication can be initiated by external ultrasonic sending and receiving equipment at any time as needed, with high real-time performance and high communication efficiency. The process has lower requirements on the circuit structure and battery capacity of the implanted end, which facilitates the miniaturization of the implantable pacemaker.
  • the above-mentioned implantable cardiac pacemaker 100 is, for example, a leadless pacemaker. Since leadless pacemakers do not use wires and have high volume requirements, using the above communication device, compared to the HBC communication method, the communication process is not affected by the cardiac cycle and can be controlled by the programmer host 210 through the ultrasonic program control head at any time. 220 initiated, high real-time performance, and because MEMS processing technology is relatively mature, it can process smaller variable acoustic impedance films 111 and piezoelectric films 112. Using the aforementioned communication method, The accuracy requirements of the ADC unit 122 and the DAC unit 123 are not high, so that the circuit complexity of the package module of the leadless cardiac pacemaker is lower, and the power consumption is also lower.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Biophysics (AREA)
  • Electrotherapy Devices (AREA)

Abstract

An implantable cardiac pacemaker, a program control apparatus, and a cardiac pacing system. In an aspect, the implantable cardiac pacemaker uses a variable acoustic impedance module to sense an ultrasonic signal, and acquires data from the outside by means of the ultrasonic signal, and in another aspect, the acoustic impedance of the variable acoustic impedance module is changed to generate a corresponding ultrasonic reflection signal, and the data are sent to the outside by means of the ultrasonic reflection signal. The implantable cardiac pacemaker communicates in a mode of acoustic impedance changes at an implanted end under a single source ultrasound.

Description

植入式心脏起搏器、程控装置以及心脏起搏系统Implantable pacemakers, programmable devices and cardiac pacing systems 技术领域Technical field
本发明涉及医学领域,尤其涉及一种植入式心脏起搏器、一种程控装置以及一种心脏起搏系统。The present invention relates to the medical field, and in particular to an implantable cardiac pacemaker, a program-controlled device and a cardiac pacing system.
背景技术Background technique
植入式心脏起搏器是近代生物医学工程对人类的一项重大贡献,植入式心脏起搏器使过去药物治疗无效的严重心律失常患者得到救治,在应用起搏器成功地治疗缓慢性心律失常、挽救了成千上万患者生命的同时,起搏器也应用到快速性心律失常及非心电性疾病,如预防阵发性房性快速心律失常、颈动脉窦晕厥、双室同步治疗药物难治性充血性心力衰竭等,大大降低了心血管疾病的死亡率。The implantable pacemaker is a major contribution of modern biomedical engineering to mankind. The implantable pacemaker allows patients with severe arrhythmias who were ineffective in drug treatment in the past to be treated. The use of pacemakers has successfully treated chronic arrhythmia. While arrhythmias have saved the lives of thousands of patients, pacemakers are also used in tachyarrhythmias and non-cardiac diseases, such as the prevention of paroxysmal atrial tachyarrhythmia, carotid sinus syncope, and biventricular synchrony. Treatment of drug-refractory congestive heart failure has significantly reduced cardiovascular disease mortality.
随着技术及应用的发展,现代植入式心脏起搏器需具备与外界双工通讯的功能,例如由体外设备对植入体内的心脏起搏器进行程控和无线遥测。同时,心脏起搏器在轻量化及小型化方面也在改进,例如目前已经开发出的植入式无导线心脏起搏器,其具有降低并发症、创伤小、植入方便及兼容MRI等优势,是未来起搏技术的发展方向。With the development of technology and applications, modern implantable pacemakers need to have the function of duplex communication with the outside world, such as program control and wireless telemetry of the pacemaker implanted in the body by external equipment. At the same time, pacemakers are also improving in terms of lightweighting and miniaturization. For example, the implantable leadless pacemaker has been developed, which has the advantages of reducing complications, less trauma, easy implantation, and compatible with MRI. , is the future development direction of pacing technology.
但是,对于植入式无导线心脏起搏器,因其体积小,电池容量小等限制,无法完全使用传统心脏起搏器采用的诸如磁感线圈及射频(RF)等无线通讯方式。据公开资料,HBC(人体通信)是植入式无导线心脏起搏器的一种可选通讯方式,其使用人体组织作为电流传导的介质,通过在起搏器电极端发放电脉冲或采集电脉冲信号,在人体表面采集或发放电脉冲信号,进行程控及遥测。但是,采用HBC通讯时,为避免影响心脏正常节律功能及避免影响正常的起搏功能,需要在不应期完成通讯,导致无法对一些实时事件信号(如心内膜事件信号)进行实时传输。此外,为了避免传输过程中的干扰,HBC通常使用频移键控等方式去调制解调,电路相对复杂,功耗也较高,在应用中仍然存在问题。 However, implantable leadless pacemakers cannot fully use wireless communication methods such as magnetic coils and radio frequency (RF) used by traditional pacemakers due to their small size and small battery capacity. According to public information, HBC (Human Body Communication) is an optional communication method for implantable leadless cardiac pacemakers. It uses human tissue as the medium for current conduction, by sending electrical pulses or collecting electrical current at the pacemaker electrode terminals. Pulse signals collect or send electrical pulse signals on the surface of the human body for program control and remote measurement. However, when using HBC communication, in order to avoid affecting the normal rhythm function of the heart and the normal pacing function, communication needs to be completed during the refractory period, which makes it impossible to transmit some real-time event signals (such as endocardial event signals) in real time. In addition, in order to avoid interference during transmission, HBC usually uses frequency shift keying and other methods to modulate and demodulate. The circuit is relatively complex and the power consumption is high, and there are still problems in application.
发明内容Contents of the invention
为了提高植入式心脏起搏器与外部通讯的实时性,本发明提供一种植入式心脏起搏器、一种程控装置以及一种心脏起搏系统。In order to improve the real-time communication between the implanted cardiac pacemaker and the outside, the present invention provides an implantable cardiac pacemaker, a program-controlled device and a cardiac pacing system.
一方面,本发明提供一种植入式心脏起搏器,包括可变声阻抗模块和信号处理模块,所述可变声阻抗模块用于感知超声信号,并将所述超声信号转换为相应的电信号后发送给所述信号处理模块,所述可变声阻抗模块的声阻抗在所述信号处理模块的控制下可改变,并生成相应的超声反射信号;所述超声信号和所述超声反射信号用于所述植入式心脏起搏器与外部通信。On the one hand, the present invention provides an implantable cardiac pacemaker, which includes a variable acoustic impedance module and a signal processing module. The variable acoustic impedance module is used to sense ultrasonic signals and convert the ultrasonic signals into corresponding electrical signals. Sent to the signal processing module, the acoustic impedance of the variable acoustic impedance module can be changed under the control of the signal processing module, and a corresponding ultrasonic reflection signal is generated; the ultrasonic signal and the ultrasonic reflection signal are used for The implantable pacemaker communicates with the outside world.
可选的,所述可变声阻抗模块包括与所述信号处理模块电连接的可变声阻抗薄膜;所述可变声阻抗薄膜的声阻抗根据所述信号处理模块的不同信号而不同,所述可变声阻抗薄膜的声阻抗根据所述信号处理模块的信号生成相应的超声反射信号。Optionally, the variable acoustic impedance module includes a variable acoustic impedance film electrically connected to the signal processing module; the acoustic impedance of the variable acoustic impedance film varies according to different signals from the signal processing module, and the variable acoustic impedance film The acoustic impedance of the impedance film generates a corresponding ultrasonic reflection signal according to the signal of the signal processing module.
可选的,所述可变声阻抗模块还包括与所述信号处理模块电连接的压电薄膜,所述压电薄膜用于感知所述超声信号,并将所述超声信号转换为相应的电信号后发送给所述信号处理模块。Optionally, the variable acoustic impedance module also includes a piezoelectric film electrically connected to the signal processing module. The piezoelectric film is used to sense the ultrasonic signal and convert the ultrasonic signal into a corresponding electrical signal. and then sent to the signal processing module.
可选的,所述植入式心脏起搏器还包括外壳,所述外壳套设在所述可变声阻抗模块和所述信号处理模块外侧,所述可变声阻抗模块还包括背衬,所述背衬设置在所述外壳内表面,所述压电薄膜和所述可变声阻抗薄膜在所述背衬上分区排布。Optionally, the implantable cardiac pacemaker further includes a shell, the shell is set outside the variable acoustic impedance module and the signal processing module, the variable acoustic impedance module further includes a backing, the A backing is provided on the inner surface of the housing, and the piezoelectric film and the variable acoustic impedance film are arranged in zones on the backing.
可选的,所述可变声阻抗模块还包括第一吸声薄膜和第二吸声薄膜,所述第一吸声薄膜位于所述压电薄膜和所述可变声阻抗薄膜之间,所述第二吸声薄膜位于所述可变声阻抗薄膜远离所述压电薄膜的一侧。Optionally, the variable acoustic impedance module further includes a first sound absorbing film and a second sound absorbing film, the first sound absorbing film is located between the piezoelectric film and the variable acoustic impedance film, and the third sound absorbing film is located between the piezoelectric film and the variable acoustic impedance film. Two sound-absorbing films are located on the side of the variable acoustic impedance film away from the piezoelectric film.
可选的,所述压电薄膜、可变声阻抗薄膜、第一吸声薄膜和第二吸声薄膜均为环状结构,且它们的轴线平行。Optionally, the piezoelectric film, the variable acoustic impedance film, the first sound-absorbing film and the second sound-absorbing film are all annular structures, and their axes are parallel.
可选的,所述第一吸声薄膜的宽度与所述第二吸声薄膜的宽度不同,且均不同于所述可变声阻抗薄膜的宽度。Optionally, the width of the first sound-absorbing film is different from the width of the second sound-absorbing film, and both are different from the width of the variable acoustic impedance film.
可选的,所述信号处理模块通过使所述可变声阻抗薄膜通电或断电来改变所述可变声阻抗模块的声阻抗。 Optionally, the signal processing module changes the acoustic impedance of the variable acoustic impedance module by energizing or de-energizing the variable acoustic impedance film.
可选的,所述信号处理模块包括处理器、ADC单元和DAC单元;所述ADC单元用于将所述可变声阻抗模块发送的电信号转换为数字信号,并发送至所述处理器;所述DAC单元用于将所述处理器发送的用于改变声阻抗的信号转换为模拟信号,并发送给所述可变声阻抗模块,所述可变声阻抗模块根据所述DAC单元发送的模拟信号调整声阻抗。Optionally, the signal processing module includes a processor, an ADC unit and a DAC unit; the ADC unit is used to convert the electrical signal sent by the variable acoustic impedance module into a digital signal and send it to the processor; The DAC unit is used to convert the signal sent by the processor for changing the acoustic impedance into an analog signal and send it to the variable acoustic impedance module. The variable acoustic impedance module adjusts according to the analog signal sent by the DAC unit. Acoustic impedance.
可选的,所述植入式心脏起搏器为无导线起搏器。Optionally, the implantable cardiac pacemaker is a leadless pacemaker.
一方面,本发明提供一种程控装置,所述程控装置包括程控仪主机和超声程控头;所述超声程控头用于发送超声信号和感知超声反射信号;所述程控仪主机通过所述超声程控头发出的超声信号向植入式心脏起搏器传输数据,并通过所述超声程控头感知的超声反射信号获得所述植入式心脏起搏器的声阻抗状态,根据所述声阻抗状态的变化获取所述植入式心脏起搏器的数据。On the one hand, the present invention provides a program-controlled device. The program-controlled device includes a program-controlled instrument host and an ultrasonic program-controlled head; the ultrasonic program-controlled head is used to send ultrasonic signals and sense ultrasonic reflection signals; the program-controlled instrument host is controlled by the ultrasonic program The ultrasonic signal emitted by the head transmits data to the implanted cardiac pacemaker, and the acoustic impedance state of the implanted cardiac pacemaker is obtained through the ultrasonic reflection signal sensed by the ultrasonic programming control head. According to the acoustic impedance state Changes to acquire data from the implantable pacemaker.
一方面,本发明提供一种心脏起搏系统,所述心脏起搏系统包括上述植入式心脏起搏器和程控装置。In one aspect, the present invention provides a cardiac pacing system, which includes the above-mentioned implantable cardiac pacemaker and a program-controlled device.
本发明提供的植入式心脏起搏器包括可变声阻抗模块和信号处理模块,所述可变声阻抗模块用于感知超声信号,并将所述超声信号转换为相应的电信号后发送给所述信号处理模块,所述可变声阻抗模块的声阻抗在所述信号处理模块的控制下可改变并生成相应的超声反射信号;所述超声信号和所述超声反射信号用于所述植入式心脏起搏器与外部通信。所述植入式心脏起搏器一方面利用可变声阻抗模块感知所述超声信号,利用该超声信号可以从外部获取数据,另一方面通过改变所述可变声阻抗模块的声阻抗,生成相应的超声反射信号,利用该超声反射信号可以向外部发送数据,由于采用超声信号和超声反射信号进行通信,而不是采用人体组织作为电流传导的介质,因此不受心动周期的影响,可根据需要随时由外部超声发送及接收设备发起通信,实时性高。并且,所述植入式心脏起搏器基于单源超声下植入端声阻抗变化的方式进行通信,通信过程对植入端的电路结构和电池容量要求较低,便于植入式心脏起搏器的小型化,例如可以采用无导线起搏器。The implantable cardiac pacemaker provided by the present invention includes a variable acoustic impedance module and a signal processing module. The variable acoustic impedance module is used to sense ultrasonic signals, convert the ultrasonic signals into corresponding electrical signals and send them to the Signal processing module, the acoustic impedance of the variable acoustic impedance module can be changed under the control of the signal processing module and generate a corresponding ultrasonic reflection signal; the ultrasonic signal and the ultrasonic reflection signal are used for the implantable heart The pacemaker communicates with the outside world. On the one hand, the implantable cardiac pacemaker uses a variable acoustic impedance module to sense the ultrasonic signal, and the ultrasonic signal can be used to obtain data from the outside. On the other hand, by changing the acoustic impedance of the variable acoustic impedance module, the corresponding Ultrasonic reflection signal, which can be used to send data to the outside. Because ultrasonic signals and ultrasonic reflection signals are used for communication instead of using human tissue as the medium for current conduction, it is not affected by the cardiac cycle and can be used at any time as needed. External ultrasound sending and receiving equipment initiates communication with high real-time performance. Moreover, the implantable cardiac pacemaker communicates based on the change of acoustic impedance of the implanted end under single-source ultrasound. The communication process has low requirements on the circuit structure and battery capacity of the implanted end, which is convenient for the implanted cardiac pacemaker. Miniaturization, such as leadless pacemakers.
本发明提供的程控装置中,超声程控头可以发送超声信号和感知超声反 射信号,所述程控仪主机则通过该超声信号向植入式心脏起搏器传输数据,并通过所述超声程控头感知的超声反射信号获得所述植入式心脏起搏器的声阻抗状态,根据所述声阻抗状态的变化获取所述植入式心脏起搏器的数据,由于采用超声信号和超声反射信号进行通信,而不是采用人体组织作为电流传导的介质,因此不受心动周期的影响,可根据需要随时由外部超声发送及接收设备发起通信,实时性高。In the program-controlled device provided by the present invention, the ultrasonic program-controlled head can send ultrasonic signals and sense ultrasonic reflections. The program controller host transmits data to the implanted cardiac pacemaker through the ultrasonic signal, and obtains the acoustic impedance state of the implanted cardiac pacemaker through the ultrasonic reflection signal sensed by the ultrasonic program control head. , the data of the implantable cardiac pacemaker is obtained according to the change of the acoustic impedance state. Since ultrasonic signals and ultrasonic reflection signals are used for communication instead of using human tissue as the medium for current conduction, it is not affected by the cardiac cycle. Impact, communication can be initiated by external ultrasonic sending and receiving equipment at any time as needed, with high real-time performance.
本发明提供的心脏起搏系统包括上述植入式心脏起搏器和程控装置,可以实现与体外设备的实时通信,而且通信过程对植入端的电路结构和电池容量要求较低,便于植入式心脏起搏器的小型化。The cardiac pacing system provided by the present invention includes the above-mentioned implantable cardiac pacemaker and a program-controlled device, which can realize real-time communication with external equipment, and the communication process has low requirements on the circuit structure and battery capacity of the implanted end, which is convenient for implantation. Miniaturization of pacemakers.
附图说明Description of drawings
图1是本发明一实施例的心脏起搏系统的示意图。Figure 1 is a schematic diagram of a cardiac pacing system according to an embodiment of the present invention.
图2是本发明一实施例的植入式心脏起搏器的示意图。Figure 2 is a schematic diagram of an implantable cardiac pacemaker according to an embodiment of the present invention.
图3是图2所示的植入式心脏起搏器中局部区域的示意图。FIG. 3 is a schematic diagram of a partial area of the implantable cardiac pacemaker shown in FIG. 2 .
图4是本发明一实施例的植入式心脏起搏器和程控装置进行通信的流程图。Figure 4 is a flow chart of communication between an implantable cardiac pacemaker and a programmable device according to an embodiment of the present invention.
图5是本发明一实施例的用于在植入式心脏起搏器100与程控装置200进行数据传输的通讯帧的示意图。FIG. 5 is a schematic diagram of a communication frame used for data transmission between the implantable cardiac pacemaker 100 and the program control device 200 according to an embodiment of the present invention.
附图标记说明:
100-植入式心脏起搏器;101-外壳;110-可变声阻抗模块;111-可变声阻
抗薄膜;112-压电薄膜;113-背衬;114-第一吸声薄膜;115-第二吸声薄膜;120-信号处理模块;121-处理器;122-ADC单元;123-DAC单元;200-程控装置;210-程控仪主机;220-超声程控头。
Explanation of reference symbols:
100-Implantable cardiac pacemaker; 101-Shell; 110-Variable acoustic impedance module; 111-Variable acoustic impedance film; 112-Piezoelectric film; 113-Backing; 114-First sound-absorbing film; 115-No. 2. Sound-absorbing film; 120-signal processing module; 121-processor; 122-ADC unit; 123-DAC unit; 200-program control device; 210-program control instrument host; 220-ultrasonic program control head.
具体实施方式Detailed ways
以下结合附图和具体实施例对本发明的植入式心脏起搏器、程控装置以及心脏起搏系统作进一步详细说明。根据下面的说明,本发明的优点和特征将更清楚。应当理解,说明书的附图均采用了非常简化的形式且均使用非精 准的比例,仅用以方便、明晰地辅助说明本发明实施例的目的。The implantable cardiac pacemaker, programmable device and cardiac pacing system of the present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments. The advantages and features of the present invention will become clearer from the following description. It should be understood that the drawings in this specification are in a very simplified form and use non-precise terms. The precise proportions are only used to conveniently and clearly assist the purpose of explaining the embodiments of the present invention.
图1是本发明一实施例的心脏起搏系统的示意图。参照图1,本发明实施例涉及一种植入式心脏起搏器100、一种程控装置200以及一种心脏起搏系统,所述心脏起搏系统包括该植入式心脏起搏器100和程控装置200,所述心脏起搏系统在工作时,植入式心脏起搏器100被植入体内,程控装置200位于体外,并且植入式心脏起搏器100和程控装置200可以采用超声信号和超声反射信号进行通信,以满足程控及遥测的需求,可应用在医生或病人通过体外的程序设置修改植入式医疗设备的参数,或者读取植入式医疗设备在工作中存储的数据等场合。具体说明如下。Figure 1 is a schematic diagram of a cardiac pacing system according to an embodiment of the present invention. Referring to Figure 1, an embodiment of the present invention relates to an implantable cardiac pacemaker 100, a program-controlled device 200 and a cardiac pacing system. The cardiac pacing system includes the implanted cardiac pacemaker 100 and a program-controlled device. Device 200, when the cardiac pacing system is working, the implantable cardiac pacemaker 100 is implanted in the body, the program control device 200 is located outside the body, and the implantable cardiac pacemaker 100 and the program control device 200 can use ultrasound signals and Ultrasonic reflection signals communicate to meet the needs of program control and telemetry. It can be used in situations such as doctors or patients modifying the parameters of implanted medical devices through in vitro program settings, or reading data stored by implanted medical devices during work. . Specific instructions are as follows.
本发明实施例的植入式心脏起搏器100包括在外壳内设置的可变声阻抗模块110和信号处理模块(图1未示出);所述可变声阻抗模块110用于感知超声信号,并将所述超声信号转换为相应的电信号后发送给所述信号处理模块;所述可变声阻抗模块110的声阻抗在所述信号处理模块的控制下可改变,并生成相应的超声反射信号;所述超声信号和所述超声反射信号用于所述植入式心脏起搏器100与外部通信。所述植入式心脏起搏器100一方面利用可变声阻抗模块110感知超声信号,利用该超声信号可以从外部获取数据,另一方面通过改变可变声阻抗模块110的声阻抗,生成相应的超声反射信号,所述超声反射信号因而随可变声阻抗模块110的声阻抗的变化而发生变化,利用该超声反射信号可以向外部发送数据。The implantable cardiac pacemaker 100 according to the embodiment of the present invention includes a variable acoustic impedance module 110 and a signal processing module (not shown in Figure 1) provided in the housing; the variable acoustic impedance module 110 is used to sense ultrasound signals, and Convert the ultrasonic signal into a corresponding electrical signal and send it to the signal processing module; the acoustic impedance of the variable acoustic impedance module 110 can be changed under the control of the signal processing module and generate a corresponding ultrasonic reflection signal; The ultrasonic signal and the ultrasonic reflection signal are used for the implantable cardiac pacemaker 100 to communicate with the outside. On the one hand, the implantable cardiac pacemaker 100 uses the variable acoustic impedance module 110 to sense ultrasonic signals, and the ultrasonic signals can be used to obtain data from the outside. On the other hand, by changing the acoustic impedance of the variable acoustic impedance module 110, it generates corresponding ultrasonic signals. The ultrasonic reflection signal changes with the change of the acoustic impedance of the variable acoustic impedance module 110, and the ultrasonic reflection signal can be used to transmit data to the outside.
图2是本发明一实施例的植入式心脏起搏器的示意图。图3是图2所示的植入式心脏起搏器中局部区域的示意图。参照图2和图3,一实施例中,植入式心脏起搏器100中的可变声阻抗模块110可包括可变声阻抗薄膜111,所述可变声阻抗薄膜111与可变声阻抗模块110中的信号处理模块电连接,所述可变声阻抗薄膜111的声阻抗根据所述信号处理模块的不同信号而不同,可变声阻抗薄膜111的声阻抗根据所述信号处理模块的信号生成相应的超声反射信号,以使植入式心脏起搏器100向外部传输数据。该实施例中,可变声阻抗模块110还包括与所述信号处理模块电连接的压电薄膜112,所述压电薄膜112用于感知超声信号,并将感知的超声信号转换为相应的电信号后发送 给所述信号处理模块。Figure 2 is a schematic diagram of an implantable cardiac pacemaker according to an embodiment of the present invention. FIG. 3 is a schematic diagram of a partial area of the implantable cardiac pacemaker shown in FIG. 2 . Referring to FIGS. 2 and 3 , in one embodiment, the variable acoustic impedance module 110 in the implantable cardiac pacemaker 100 may include a variable acoustic impedance film 111 , and the variable acoustic impedance film 111 is consistent with the variable acoustic impedance module 110 . The signal processing module is electrically connected. The acoustic impedance of the variable acoustic impedance film 111 is different according to different signals of the signal processing module. The acoustic impedance of the variable acoustic impedance film 111 generates a corresponding ultrasonic reflection signal according to the signal of the signal processing module. , so that the implantable cardiac pacemaker 100 transmits data to the outside. In this embodiment, the variable acoustic impedance module 110 also includes a piezoelectric film 112 electrically connected to the signal processing module. The piezoelectric film 112 is used to sense ultrasonic signals and convert the sensed ultrasonic signals into corresponding electrical signals. Send later to the signal processing module.
上述可变声阻抗模块110中的可变声阻抗薄膜111和压电薄膜112均可包括压电层、设置于该压电层的一侧表面的第一电极和设置于该压电层另一侧表面的第二电极,所述压电层可采用聚偏氟乙烯(PVDF)、氮化铝(AlN)、氧化锌(ZnO)、锆钛酸铅(PZT)、氧化铌锂(LiNbO3)、氧化钽锂(LiTaO3)、或其它压电材料中的一种或多种。Both the variable acoustic impedance film 111 and the piezoelectric film 112 in the variable acoustic impedance module 110 may include a piezoelectric layer, a first electrode disposed on one side surface of the piezoelectric layer, and a first electrode disposed on the other side surface of the piezoelectric layer. The second electrode, the piezoelectric layer can be made of polyvinylidene fluoride (PVDF), aluminum nitride (AlN), zinc oxide (ZnO), lead zirconate titanate (PZT), lithium niobium oxide (LiNbO3), tantalum oxide Lithium (LiTaO3), or one or more of other piezoelectric materials.
图2和图3所示的实施例中,可变声阻抗模块110采用可变声阻抗薄膜111生成超声反射信号,并另外采用压电薄膜112感知超声信号,从而可变声阻抗薄膜11和压电薄膜112的信号处理过程互不干涉,所述信号处理模块可以在接收压电薄膜112基于感知到的超声信号生成的电信号的同时,向可变声阻抗薄膜111发送另一电信号,故可实现全双工通信。本发明不限于此,在另一实施例中,可变声阻抗模块110也可以不设置压电薄膜112,而是由用于生成超声反射信号的可变声阻抗薄膜111感知超声信号,并将所述超声信号转换为相应的电信号后发送给所述信号处理模块,该可变声阻抗薄膜111处理所述超声信号的过程和生成所述超声反射信号的过程可以分时进行。In the embodiment shown in FIGS. 2 and 3 , the variable acoustic impedance module 110 uses a variable acoustic impedance film 111 to generate an ultrasonic reflection signal, and additionally uses a piezoelectric film 112 to sense the ultrasonic signal, so that the variable acoustic impedance film 11 and the piezoelectric film 112 The signal processing processes do not interfere with each other. The signal processing module can send another electrical signal to the variable acoustic impedance film 111 while receiving the electrical signal generated by the piezoelectric film 112 based on the sensed ultrasonic signal, so it can achieve full dual Industrial communications. The present invention is not limited to this. In another embodiment, the variable acoustic impedance module 110 may not be provided with the piezoelectric film 112 , but may use the variable acoustic impedance film 111 for generating ultrasonic reflection signals to sense the ultrasonic signal, and use the variable acoustic impedance film 111 to generate the ultrasonic reflection signal. The ultrasonic signal is converted into a corresponding electrical signal and then sent to the signal processing module. The process of processing the ultrasonic signal by the variable acoustic impedance film 111 and the process of generating the ultrasonic reflection signal can be performed in a time-sharing manner.
参照图1至图3,植入式心脏起搏器100还可包括外壳101,所述外壳101套设在上述可变声阻抗模块110和所述信号处理模块外侧。所述可变声阻抗模块110还可包括背衬113,背衬113设置在外壳101的内表面,上述压电薄膜112和可变声阻抗薄膜111在背衬113上分区排布。来自外部的超声信号到达背衬113,并被压电薄膜112感知。Referring to FIGS. 1 to 3 , the implantable cardiac pacemaker 100 may further include a housing 101 , which is set outside the variable acoustic impedance module 110 and the signal processing module. The variable acoustic impedance module 110 may further include a backing 113 disposed on the inner surface of the housing 101 , and the piezoelectric film 112 and the variable acoustic impedance film 111 are arranged in zones on the backing 113 . Ultrasonic signals from the outside reach the backing 113 and are sensed by the piezoelectric film 112 .
所述可变声阻抗模块110还可包括第一吸声薄膜114和第二吸声薄膜115,第一吸声薄膜114和第二吸声薄膜115例如位于背衬113的里表面。所述第一吸声薄膜114位于压电薄膜112和可变声阻抗薄膜111之间,从而将二者隔离,所述第二吸声薄膜115位于可变声阻抗薄膜111远离压电薄膜112的一侧。利用第一吸声薄膜114和第二吸声薄膜115,便于确定超声反射信号的发射位置,进而基于发射位置找到并检测可变声阻抗薄膜111的状态。第一吸声薄膜114和第二吸声薄膜115的宽度方向沿压电薄膜112和可变声阻抗薄膜111的排布方向。为了提高定位的精确性,可设置所述第一吸声薄膜114 的宽度与所述第二吸声薄膜115的宽度不同,且均不同于可变声阻抗薄膜111的宽度。如图3所示,一实施例中,第二吸声薄膜115的宽度大于可变声阻抗薄膜111的宽度,且第一吸声薄膜114的宽度小于可变声阻抗薄膜111的宽度,但不限于此,另一实施例中,第二吸声薄膜115的宽度小于可变声阻抗薄膜111的宽度,且第一吸声薄膜114的宽度大于可变声阻抗薄膜111的宽度。The variable acoustic impedance module 110 may further include a first sound-absorbing film 114 and a second sound-absorbing film 115 , which are, for example, located on the inner surface of the backing 113 . The first sound-absorbing film 114 is located between the piezoelectric film 112 and the variable acoustic impedance film 111 to isolate them. The second sound-absorbing film 115 is located on the side of the variable acoustic impedance film 111 away from the piezoelectric film 112 . The first sound-absorbing film 114 and the second sound-absorbing film 115 are used to determine the emission position of the ultrasonic reflection signal, and then find and detect the state of the variable acoustic impedance film 111 based on the emission position. The width direction of the first sound absorbing film 114 and the second sound absorbing film 115 is along the arrangement direction of the piezoelectric film 112 and the variable acoustic impedance film 111 . In order to improve the positioning accuracy, the first sound-absorbing film 114 can be provided The width of is different from the width of the second sound-absorbing film 115, and both are different from the width of the variable acoustic impedance film 111. As shown in Figure 3, in one embodiment, the width of the second sound-absorbing film 115 is greater than the width of the variable acoustic impedance film 111, and the width of the first sound-absorbing film 114 is smaller than the width of the variable acoustic impedance film 111, but is not limited thereto. , in another embodiment, the width of the second sound-absorbing film 115 is smaller than the width of the variable acoustic impedance film 111 , and the width of the first sound-absorbing film 114 is larger than the width of the variable acoustic impedance film 111 .
考虑到超声波在体内的穿透、反射及折射较为复杂,而植入式心脏起搏器100在植入人体时,其面对人胸腔的体面不容易控制,因此,为了方便超声定位,植入式心脏起搏器100的外壳101可选用如图2所示的柱体结构(例如为圆柱体结构,圆柱体结构的外侧面为圆柱面),植入式心脏起搏器100的电池可设置在该柱体结构内。可变声阻抗模块110可采用空心环状结构设置在该柱体结构内,空心能够通过电极馈通。示例的,上述压电薄膜112、可变声阻抗薄膜111、第一吸声薄膜114和第二吸声薄膜115可在外壳101内首尾连接,即均设置为环状结构,所述压电薄膜112、可变声阻抗薄膜111、第一吸声薄膜114和第二吸声薄膜115的轴线例如是平行的。所述环状结构的轴线可设置为与外壳101的轴线平行。第一吸声薄膜114和第二吸声薄膜115构成如图2所示的吸声环。超声信号从上述柱体结构的侧面被可变声阻抗模块110感应,这种方式对植入式心脏起搏器100体面的朝向要求不高,不受植入位置的影响。需要说明的是,图2和图3中压电薄膜112、可变声阻抗薄膜111、第一吸声薄膜114和第二吸声薄膜115的形状和位置仅是示例,在另外的实施例中,它们中的任意一个均可采用其它的形状和/或位置。背衬113可与植入式心脏起搏器100的外壳101包括相同的材质,例如钛。吸声环例如为氧化硅或者其它材质。Considering that the penetration, reflection and refraction of ultrasonic waves in the body are relatively complex, and when the implantable pacemaker 100 is implanted in the human body, its face facing the human chest is not easy to control. Therefore, in order to facilitate ultrasonic positioning, the implanted pacemaker 100 is The housing 101 of the implantable pacemaker 100 can be a cylindrical structure as shown in Figure 2 (for example, a cylindrical structure, the outer surface of the cylindrical structure is a cylindrical surface), and the battery of the implantable pacemaker 100 can be configured within the column structure. The variable acoustic impedance module 110 can be arranged in the column structure using a hollow ring structure, and the hollow can be fed through the electrodes. For example, the above-mentioned piezoelectric film 112, variable acoustic impedance film 111, first sound-absorbing film 114 and second sound-absorbing film 115 can be connected end to end in the housing 101, that is, they are all arranged in a ring structure. The piezoelectric film 112 The axes of the variable acoustic impedance film 111, the first sound absorbing film 114 and the second sound absorbing film 115 are, for example, parallel. The axis of the annular structure may be arranged parallel to the axis of the housing 101 . The first sound-absorbing film 114 and the second sound-absorbing film 115 form a sound-absorbing ring as shown in FIG. 2 . The ultrasonic signal is sensed by the variable acoustic impedance module 110 from the side of the above-mentioned cylindrical structure. This method does not have high requirements on the orientation of the implantable pacemaker 100 and is not affected by the implantation position. It should be noted that the shapes and positions of the piezoelectric film 112, the variable acoustic impedance film 111, the first sound-absorbing film 114 and the second sound-absorbing film 115 in Figures 2 and 3 are only examples. In other embodiments, Any of them may adopt other shapes and/or positions. The backing 113 may comprise the same material as the housing 101 of the implantable pacemaker 100, such as titanium. The sound-absorbing ring is made of silicon oxide or other materials, for example.
图4是本发明一实施例的植入式心脏起搏器和程控装置进行通信的流程图。参照图2至图4,本发明实施例中,植入式心脏起搏器100中的信号处理模块记为信号处理模块120,该信号处理模块120可包括处理器121和ADC单元122,所述ADC单元122用于将可变声阻抗模块110发送(例如由压电薄膜112发送)的电信号(例如为模拟信号)转换为数字信号,并发送至处理器121。所述处理器121还采用对植入式心脏起搏器100中用于控制起搏功 能的处理器,以节约体积。所述处理器121可包括逻辑可分离软件(计算机程序)、硬件或等效部件。该处理器121例如为一芯片。本实施例对处理器的具体结构不作特别限定。Figure 4 is a flow chart of communication between an implantable cardiac pacemaker and a programmable device according to an embodiment of the present invention. Referring to Figures 2 to 4, in the embodiment of the present invention, the signal processing module in the implantable cardiac pacemaker 100 is denoted as signal processing module 120. The signal processing module 120 may include a processor 121 and an ADC unit 122. The ADC unit 122 is used to convert an electrical signal (eg, an analog signal) sent by the variable acoustic impedance module 110 (eg, sent by the piezoelectric film 112 ) into a digital signal, and send it to the processor 121 . The processor 121 also uses the implantable cardiac pacemaker 100 to control the pacing function. capable processor to save space. The processor 121 may include logically separable software (computer program), hardware, or equivalent components. The processor 121 is, for example, a chip. The specific structure of the processor is not particularly limited in this embodiment.
所述处理器121可根据接收到的电信号可生成反馈信号,并可以将植入式心脏起搏器100存储或感知的数据向外部发送。在向外部发送该反馈信号或数据时,为了改变可变声阻抗模块110的声阻抗,一实施例中,所述信号处理模块120还可包括DAC单元123,所述DAC单元123用于将处理器121发送的用于改变声阻抗的信号(为数字信号)转换为模拟信号,并发送给可变声阻抗模块110(具体发送至可变声阻抗薄膜111),所述可变声阻抗模块110可根据DAC单元123发送的模拟信号调整声阻抗。参照图2,压电薄膜112的一个电极(例如正极,以“+”表示)通过ADC单元122与处理器121连接,另一个电极(例如负极,以“-”表示)也与该处理器121连接,以形成回路。可变声阻抗薄膜111的一个电极(例如正极,以“+”表示)通过DAC单元123与处理器121连接,另一个电极(例如负极,以“-”表示)也与该处理器121连接,以形成回路。ADC单元122和DAC单元123可以分别由不同的设备实现,也可以由同一设备实现,本实施例对此不作特别限定。The processor 121 can generate a feedback signal according to the received electrical signal, and can send the data stored or sensed by the implantable pacemaker 100 to the outside. When sending the feedback signal or data to the outside, in order to change the acoustic impedance of the variable acoustic impedance module 110, in an embodiment, the signal processing module 120 may also include a DAC unit 123, the DAC unit 123 is used to convert the processor The signal (which is a digital signal) sent by 121 for changing the acoustic impedance is converted into an analog signal and sent to the variable acoustic impedance module 110 (specifically sent to the variable acoustic impedance film 111). The variable acoustic impedance module 110 can be configured according to the DAC unit. The analog signal sent by 123 adjusts the acoustic impedance. Referring to FIG. 2 , one electrode (such as the positive electrode, represented by “+”) of the piezoelectric film 112 is connected to the processor 121 through the ADC unit 122 , and the other electrode (such as the negative electrode, represented by “-”) is also connected to the processor 121 Connect to form a loop. One electrode (such as the positive electrode, represented by "+") of the variable acoustic impedance film 111 is connected to the processor 121 through the DAC unit 123, and the other electrode (such as the negative electrode, represented by "-") is also connected to the processor 121, so as to Form a loop. The ADC unit 122 and the DAC unit 123 may be implemented by different devices, or may be implemented by the same device, which is not particularly limited in this embodiment.
本发明实施例的植入式心脏起搏器100,一方面利用可变声阻抗模块110感知超声信号,利用该超声信号可以从外部获取数据,另一方面通过改变可变声阻抗模块110的声阻抗,生成相应的超声反射信号,利用该超声反射信号可以向外部发送数据。一实施例中,植入式心脏起搏器100为无导线起搏器,无导线起搏器不需要连接导线,体积小,在采用上述超声信号和超声反射信号与外部进行通信时,不仅可以根据需要随时由位于体外的超声发送及接收设备发起通信,实时性高,而且可以基于单源超声下植入端声阻抗变化的方式进行通信,不需要显著增大无导线起搏器的体积,对电池容量的要求较低,通信过程对植入端的电路结构和电池容量要求较低。The implantable cardiac pacemaker 100 in the embodiment of the present invention, on the one hand, uses the variable acoustic impedance module 110 to sense ultrasonic signals, and the ultrasonic signals can be used to obtain data from the outside. On the other hand, by changing the acoustic impedance of the variable acoustic impedance module 110, A corresponding ultrasonic reflection signal is generated, which can be used to send data to the outside. In one embodiment, the implantable cardiac pacemaker 100 is a leadless pacemaker. The leadless pacemaker does not need to be connected to wires and is small in size. When using the above-mentioned ultrasonic signals and ultrasonic reflection signals to communicate with the outside, it can not only Communication is initiated by the ultrasound transmitting and receiving equipment located outside the body at any time as needed, which is highly real-time and can communicate based on changes in the acoustic impedance of the implanted end under single-source ultrasound without significantly increasing the size of the leadless pacemaker. The requirements for battery capacity are low, and the communication process has low requirements for the circuit structure and battery capacity of the implanted end.
本发明实施例还包括一种程控装置,用户可通过该程控装置设置及读取上述植入式心脏起搏器100的参数和存储数据。参照图1和图4,本发明实施例中,程控装置200包括程控仪主机210和超声程控头220,二者可通过线缆 连接。所述超声程控头220用于发送超声信号和感知超声反射信号,例如可以在所述程控仪主机210的控制下发出超声信号,还可以感知发出的超声信号经目标位置的物体(此处为植入式心脏起搏器100中的可变声阻抗模块110)反射后得到的超声反射信号,该超声反射信号可转换为相应的电信号后发送给程控仪主机210。程控仪主机210通过超声程控头220发出的超声信号向植入式心脏起搏器传输数据,并通过所述超声程控头220感知的超声反射信号获得所述植入式心脏起搏器的声阻抗状态,根据所述声阻抗状态的变化获取植入式心脏起搏器100的数据,即采用单源超声模式实现了与植入式心脏起搏器通信的功能。程控仪主机210可包括控制系统、显示器及输入输出设备等,所述超声信号和超声反射信号例如均为脉冲信号,以便于数据传输。本实施例对程控仪主机210和超声程控头220的具体结构不作特别限定。Embodiments of the present invention also include a program-controlled device through which a user can set and read parameters and stored data of the above-mentioned implantable pacemaker 100. Referring to Figures 1 and 4, in the embodiment of the present invention, the program control device 200 includes a program control instrument host 210 and an ultrasonic program control head 220, both of which can be connected via cables. connect. The ultrasonic program control head 220 is used to send ultrasonic signals and sense ultrasonic reflection signals. For example, it can send out ultrasonic signals under the control of the program controller host 210 and can also sense the object (here, a plant) where the emitted ultrasonic signal passes through the target position. The ultrasonic reflection signal obtained after reflection by the variable acoustic impedance module 110 in the implantable cardiac pacemaker 100 can be converted into a corresponding electrical signal and then sent to the program controller host 210. The program controller host 210 transmits data to the implanted cardiac pacemaker through the ultrasonic signal sent by the ultrasonic program control head 220, and obtains the acoustic impedance of the implanted cardiac pacemaker through the ultrasonic reflection signal sensed by the ultrasonic program control head 220. state, and the data of the implantable cardiac pacemaker 100 is obtained according to the change in the acoustic impedance state, that is, the single-source ultrasound mode is used to realize the function of communicating with the implanted cardiac pacemaker. The program controller host 210 may include a control system, a display, an input and output device, etc. The ultrasonic signal and the ultrasonic reflection signal are, for example, pulse signals to facilitate data transmission. In this embodiment, the specific structures of the program controller host 210 and the ultrasonic program control head 220 are not particularly limited.
本发明实施例的程控装置200采用超声信号和超声反射信号进行通信,而不是采用人体组织作为电流传导的介质,因此不受心动周期的影响,可根据需要随时由外部超声发送及接收设备发起通信,实时性高。The program-controlled device 200 in the embodiment of the present invention uses ultrasonic signals and ultrasonic reflection signals for communication instead of using human tissue as the medium for current conduction. Therefore, it is not affected by the cardiac cycle and can initiate communication at any time by external ultrasonic sending and receiving equipment as needed. , high real-time performance.
如图1所示,本发明实施例的心脏起搏系统包括上述植入式心脏起搏器100和程控装置200。As shown in FIG. 1 , the cardiac pacing system according to the embodiment of the present invention includes the above-mentioned implantable cardiac pacemaker 100 and a program control device 200 .
仍参考图4,示例的,所述心脏起搏系统中植入式心脏起搏器100和程控装置200进行数据传输时可包括如下过程:当用户需要程控数据至植入式心脏起搏器100时,程控仪主机210准备相关的数据,通过超声程控头220将数据转换为超声信号,可变声阻抗模块110感知超声信号及其变化,并向信号处理模块120发送相应的模拟电信号,信号处理模块120通过ADC单元122将其转换为数字信号,传输至处理器121,从而实现体外至体内数据的发送,如图4中的流程A所示;当用于需要读取植入式心脏起搏器100存储的数据时,超声程控头220先发送一超声信号,处理器121先通过与流程A相同的路径接收到相应的指令,基于该指令向超声程控头220发送数据,处理器121发送的数字信号通过DAC单元123转换为模拟信号,在该模拟信号的作用下,可变声阻抗模块110的声阻抗发生变化,此时超声程控头220发送的超声信号在可变声阻抗模块110形成的超声反射信号发生改变,超声程控头220感 测到被改变的超声反射信号,转换为相应的电信号后将数据返回至程控仪主机210,从而实现体内至体外数据的发送,如图4中的流程B所示。Still referring to FIG. 4 , as an example, the data transmission between the implanted cardiac pacemaker 100 and the programming device 200 in the cardiac pacing system may include the following process: when the user needs to program data to the implanted cardiac pacemaker 100 At this time, the program controller host 210 prepares relevant data and converts the data into ultrasonic signals through the ultrasonic program control head 220. The variable acoustic impedance module 110 senses the ultrasonic signals and their changes, and sends corresponding analog electrical signals to the signal processing module 120. Signal processing The module 120 converts it into a digital signal through the ADC unit 122 and transmits it to the processor 121, thereby realizing the transmission of data from outside the body to the body, as shown in process A in Figure 4; when it is necessary to read the implanted cardiac pacing When receiving the data stored in the processor 100, the ultrasonic program control head 220 first sends an ultrasonic signal, the processor 121 first receives the corresponding instruction through the same path as process A, and sends data to the ultrasonic program control head 220 based on the instruction. The processor 121 sends The digital signal is converted into an analog signal through the DAC unit 123. Under the action of the analog signal, the acoustic impedance of the variable acoustic impedance module 110 changes. At this time, the ultrasonic signal sent by the ultrasonic program control head 220 is reflected by the ultrasonic reflection formed by the variable acoustic impedance module 110. The signal changes, the ultrasonic program control head 220 senses The changed ultrasonic reflection signal is detected, converted into a corresponding electrical signal, and then returned to the program controller host 210, thereby realizing the transmission of data from the inside to the outside of the body, as shown in process B in Figure 4.
所述心脏起搏系统中,在植入式心脏起搏器100向外部发送反馈信号或数据时,为了改变可变声阻抗模块110的声阻抗,一实施例中,植入式心脏起搏器100内的信号处理模块可控制使所述可变声阻抗薄膜111通电或断电,所述可变声阻抗薄膜111在通电时或断电时会体现出不同的声阻抗,因而通过通断电的操作也可以改变可变声阻抗模块110的声阻抗。In the cardiac pacing system, when the implantable cardiac pacemaker 100 sends feedback signals or data to the outside, in order to change the acoustic impedance of the variable acoustic impedance module 110, in one embodiment, the implantable cardiac pacemaker 100 The signal processing module inside can control the variable acoustic impedance film 111 to be powered on or off. The variable acoustic impedance film 111 will exhibit different acoustic impedances when powered on or off. Therefore, the operation of turning on and off the power can also The acoustic impedance of variable acoustic impedance module 110 may be varied.
以下示例地对在植入式心脏起搏器100和程控装置200之间传输的通信数据进行说明。The communication data transmitted between the implantable cardiac pacemaker 100 and the programming device 200 is described below by way of example.
一实施例中,在程控装置200接收体内反射回来的超声反射信号时,当植入式心脏起搏器100中可变声阻抗模块110的声阻抗未发生变化时,程控装置200接收到对应的超声反射信号后,将相应的声阻抗状态记为第一电平,当可变声阻抗模块110的声阻抗发生变化时,程控装置200接收到对应的超声反射信号后,将相应的声阻抗状态记为第二电平,所述第二电平与第一电平相反。例如,可设置从超声程控头220探知可变声阻抗薄膜111未通电时的声阻抗状态记为0,当有电流通过时的声阻抗状态记为1。In one embodiment, when the program control device 200 receives the ultrasonic reflection signal reflected back from the body, when the acoustic impedance of the variable acoustic impedance module 110 in the implantable cardiac pacemaker 100 does not change, the program control device 200 receives the corresponding ultrasonic signal. After reflecting the signal, the corresponding acoustic impedance state is recorded as the first level. When the acoustic impedance of the variable acoustic impedance module 110 changes, the program control device 200 receives the corresponding ultrasonic reflection signal and records the corresponding acoustic impedance state as a second level, which is opposite to the first level. For example, the acoustic impedance state detected from the ultrasonic program control head 220 when the variable acoustic impedance film 111 is not energized can be recorded as 0, and the acoustic impedance state when there is current flowing through it can be recorded as 1.
一实施例中,当可变声阻抗模块110未感知到程控装置200发送的超声信号时,处理器121以第一电平作为所述超声信号的电平,当可变声阻抗模块110感知到程控装置200发送的超声信号时,处理器121将第二电平作为所述超声信号的电平,所述第二电平与所述第一电平相反。例如,上述压电薄膜112感知到超声程控头220发射的超声信号时,处理器121获得电压变化,记为1,当未感知到超声信号时,则无电压或无电压变化,则记为0。上述通讯方式由超声程控头220完成了超声信号的发射和感知,通讯过程中的数据可采用脉冲信号,脉冲宽度可根据实际需求进行调整。此种编码方式仅考量电压信号是否有变化,对ADC单元122和DAC单元123的精度要求不高,便于系统设计与集成。本发明不限于此,在另外的实施例中,也可以采用其它通讯信号设置。In one embodiment, when the variable acoustic impedance module 110 does not sense the ultrasonic signal sent by the program-controlled device 200, the processor 121 uses the first level as the level of the ultrasonic signal. When the variable acoustic impedance module 110 senses that the program-controlled device 200 When the ultrasonic signal is sent by 200, the processor 121 uses the second level as the level of the ultrasonic signal, and the second level is opposite to the first level. For example, when the above-mentioned piezoelectric film 112 senses the ultrasonic signal emitted by the ultrasonic program control head 220, the processor 121 obtains the voltage change, which is recorded as 1. When no ultrasonic signal is sensed, there is no voltage or no voltage change, which is recorded as 0. . In the above communication method, the ultrasonic program control head 220 completes the transmission and sensing of ultrasonic signals. The data in the communication process can use pulse signals, and the pulse width can be adjusted according to actual needs. This encoding method only considers whether there are changes in the voltage signal, and does not require high accuracy for the ADC unit 122 and DAC unit 123, which facilitates system design and integration. The present invention is not limited to this. In other embodiments, other communication signal settings may also be used.
在植入式心脏起搏器100与程控装置200传输的数据例如按周期发送。 每个通讯周期传输的数据称为通讯帧,每个通讯帧包括帧头端和帧数据,均可由体外的程控仪主机210通过超声程控头220发起。为了避免干扰或植入式心脏起搏器100产生错误感知,可通过设定序列进行通讯。图5是本发明一实施例的用于在植入式心脏起搏器100与程控装置200进行数据传输的通讯帧的示意图。参照图5,为了方便解释,将数据段进行编号。编号1示例由5bit二进制数据组成,表示超声程控头220发送的超声信号序列。编号2是当处理器121收到此序列后改变声阻抗的信息,示例由3bit二进制数据组成。在发送编号1和编号2的数据后且超声程控头220感知到处理器121的响应数据后,发送编号3,编号3代表此次通讯由哪一端传递数据。示例的,01代表程控装置200需要传递数据。10代表植入式心脏起搏器100传递数据。当帧头端数据传递完毕,开始传递帧数据。帧数据包含表示整帧数据长度的数据段4(示例为8bit)、表示校验(checksum)的数据段5以及表示当次通讯要传输的数据的数据段6。如果植入式心脏起搏器100无数据传递,则可设置回复0xFF(帧数据长度)结束本次通讯。The data transmitted between the implantable cardiac pacemaker 100 and the program control device 200 is sent periodically, for example. The data transmitted in each communication cycle is called a communication frame. Each communication frame includes a frame header and frame data, which can be initiated by the external programmer host 210 through the ultrasonic program control head 220. In order to avoid interference or false sensing of the implanted cardiac pacemaker 100, communication can be performed through a set sequence. FIG. 5 is a schematic diagram of a communication frame used for data transmission between the implantable cardiac pacemaker 100 and the program control device 200 according to an embodiment of the present invention. Referring to Figure 5, the data segments are numbered for convenience of explanation. Example No. 1 consists of 5-bit binary data and represents the ultrasonic signal sequence sent by the ultrasonic program control head 220. Number 2 is information that changes the acoustic impedance when the processor 121 receives this sequence. The example consists of 3-bit binary data. After sending data No. 1 and No. 2 and after the ultrasonic program control head 220 senses the response data from the processor 121, No. 3 is sent. No. 3 represents which end of this communication transmits the data. For example, 01 represents that the program-controlled device 200 needs to transmit data. 10 represents the implantable pacemaker 100 transmitting data. When the frame header data is transmitted, the frame data begins to be transmitted. The frame data includes a data segment 4 that represents the length of the entire frame (8 bits in the example), a data segment 5 that represents a checksum, and a data segment 6 that represents the data to be transmitted in the current communication. If there is no data transmission from the implantable pacemaker 100, a reply of 0xFF (frame data length) can be set to end this communication.
所述心脏起搏系统基于单源超声,可在体外使用程控装置200探测植入式心脏起搏器100中可变声阻抗模块110的声阻抗的变化,利用声阻抗的变化作为信息的载体,可实现植入式心脏起搏器100到程控装置200的被动式通讯,同时,可变声阻抗模块110可感知超声信号并实现超声信号到电信号的转换,因而还可实现体外到体内的通讯,即能够实现双工通信。由于采用超声信号和超声反射信号进行通信,而不是采用人体组织作为电流传导的介质,因此不受心动周期的影响,可根据需要随时由外部超声发送及接收设备发起通信,实时性高,而且通信过程对植入端的电路结构和电池容量要求较低,便于植入式心脏起搏器的小型化。The cardiac pacing system is based on single-source ultrasound, and can use the program-controlled device 200 to detect changes in the acoustic impedance of the variable acoustic impedance module 110 in the implantable cardiac pacemaker 100 outside the body. The changes in acoustic impedance can be used as a carrier of information. Passive communication between the implantable cardiac pacemaker 100 and the program-controlled device 200 is realized. At the same time, the variable acoustic impedance module 110 can sense the ultrasonic signal and convert the ultrasonic signal into an electrical signal, so it can also realize communication from outside the body to the body, that is, it can Enables duplex communication. Since ultrasonic signals and ultrasonic reflected signals are used for communication instead of using human tissue as the medium for current conduction, it is not affected by the cardiac cycle. Communication can be initiated by external ultrasonic sending and receiving equipment at any time as needed, with high real-time performance and high communication efficiency. The process has lower requirements on the circuit structure and battery capacity of the implanted end, which facilitates the miniaturization of the implantable pacemaker.
上述植入式心脏起搏器100例如是无导线起搏器。由于无导线起搏器不采用导线,且对体积的要求较高,利用上述通讯装置,相对于HBC通讯方式,通讯过程不受心动周期影响,可在任何时候由程控仪主机210通过超声程控头220发起,实时性高,而且,由于MEMS加工技术较为成熟,可以加工尺寸较小的可变声阻抗薄膜111以及压电薄膜112,采用前述的通讯方式,对 ADC单元122和DAC单元123的精度要求不高,使得无导线心脏起搏器的封装模块电路复杂度较低,且功耗也较低。The above-mentioned implantable cardiac pacemaker 100 is, for example, a leadless pacemaker. Since leadless pacemakers do not use wires and have high volume requirements, using the above communication device, compared to the HBC communication method, the communication process is not affected by the cardiac cycle and can be controlled by the programmer host 210 through the ultrasonic program control head at any time. 220 initiated, high real-time performance, and because MEMS processing technology is relatively mature, it can process smaller variable acoustic impedance films 111 and piezoelectric films 112. Using the aforementioned communication method, The accuracy requirements of the ADC unit 122 and the DAC unit 123 are not high, so that the circuit complexity of the package module of the leadless cardiac pacemaker is lower, and the power consumption is also lower.
需要说明的是,本说明书中各个实施例采用递进的方式描述,每个实施例重点说明的都是与其他实施例的不同之处,各个实施例之间相同和相似的部分互相参见即可。It should be noted that each embodiment in this specification is described in a progressive manner. Each embodiment focuses on the differences from other embodiments. The same and similar parts between the various embodiments can be referred to each other. .
上述描述仅是对本发明较佳实施例的描述,并非对本发明权利范围的任何限定,任何本领域技术人员在不脱离本发明的精神和范围内,都可以利用上述揭示的方法和技术内容对本发明技术方案做出可能的变动和修改,因此,凡是未脱离本发明技术方案的内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化及修饰,均属于本发明技术方案的保护范围。 The above description is only a description of the preferred embodiments of the present invention, and does not limit the scope of rights of the present invention. Any person skilled in the art can use the methods and technical contents disclosed above to improve the present invention without departing from the spirit and scope of the present invention. Possible changes and modifications are made to the technical solution. Therefore, any simple modifications, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention, all belong to the technical solution of the present invention. protected range.

Claims (12)

  1. 一种植入式心脏起搏器,其特征在于,包括可变声阻抗模块和信号处理模块,所述可变声阻抗模块用于感知超声信号,并将所述超声信号转换为相应的电信号后发送给所述信号处理模块,所述可变声阻抗模块的声阻抗在所述信号处理模块的控制下可改变,并生成相应的超声反射信号;所述超声信号和所述超声反射信号用于所述植入式心脏起搏器与外部通信。An implantable cardiac pacemaker, characterized by comprising a variable acoustic impedance module and a signal processing module. The variable acoustic impedance module is used to sense ultrasonic signals, convert the ultrasonic signals into corresponding electrical signals and send them to The signal processing module, the acoustic impedance of the variable acoustic impedance module can be changed under the control of the signal processing module, and generates a corresponding ultrasonic reflection signal; the ultrasonic signal and the ultrasonic reflection signal are used for the implant Implantable pacemaker communicates with the outside world.
  2. 如权利要求1所述的植入式心脏起搏器,其特征在于,所述可变声阻抗模块包括与所述信号处理模块电连接的可变声阻抗薄膜;所述可变声阻抗薄膜的声阻抗根据所述信号处理模块的不同信号而不同,所述可变声阻抗薄膜的声阻抗根据所述信号处理模块的信号生成相应的超声反射信号。The implantable cardiac pacemaker of claim 1, wherein the variable acoustic impedance module includes a variable acoustic impedance film electrically connected to the signal processing module; the acoustic impedance of the variable acoustic impedance film is based on Different signals from the signal processing module are different, and the acoustic impedance of the variable acoustic impedance film generates corresponding ultrasonic reflection signals according to the signals from the signal processing module.
  3. 如权利要求2所述的植入式心脏起搏器,其特征在于,所述可变声阻抗模块还包括与所述信号处理模块电连接的压电薄膜,所述压电薄膜用于感知所述超声信号,并将所述超声信号转换为相应的电信号后发送给所述信号处理模块。The implantable cardiac pacemaker of claim 2, wherein the variable acoustic impedance module further includes a piezoelectric film electrically connected to the signal processing module, and the piezoelectric film is used to sense the Ultrasonic signals are converted into corresponding electrical signals and sent to the signal processing module.
  4. 如权利要求3所述的植入式心脏起搏器,其特征在于,还包括外壳,所述外壳套设在所述可变声阻抗模块和所述信号处理模块外侧,所述可变声阻抗模块还包括背衬,所述背衬设置在所述外壳内表面,所述压电薄膜和所述可变声阻抗薄膜在所述背衬上分区排布。The implantable cardiac pacemaker according to claim 3, further comprising a shell, the shell being set outside the variable acoustic impedance module and the signal processing module, the variable acoustic impedance module further It includes a backing, the backing is arranged on the inner surface of the housing, and the piezoelectric film and the variable acoustic impedance film are arranged in zones on the backing.
  5. 如权利要求4所述的植入式心脏起搏器,其特征在于,所述可变声阻抗模块还包括第一吸声薄膜和第二吸声薄膜,所述第一吸声薄膜位于所述压电薄膜和所述可变声阻抗薄膜之间,所述第二吸声薄膜位于所述可变声阻抗薄膜远离所述压电薄膜的一侧。The implantable cardiac pacemaker of claim 4, wherein the variable acoustic impedance module further includes a first sound-absorbing film and a second sound-absorbing film, the first sound-absorbing film being located on the pressure Between the electric film and the variable acoustic impedance film, the second sound absorbing film is located on the side of the variable acoustic impedance film away from the piezoelectric film.
  6. 如权利要求5所述的植入式心脏起搏器,其特征在于,所述压电薄膜、可变声阻抗薄膜、第一吸声薄膜和第二吸声薄膜均为环状结构,且它们的轴线平行。 The implantable cardiac pacemaker of claim 5, wherein the piezoelectric film, the variable acoustic impedance film, the first sound-absorbing film and the second sound-absorbing film are annular structures, and their The axes are parallel.
  7. 如权利要求6所述的植入式心脏起搏器,其特征在于,所述第一吸声薄膜的宽度与所述第二吸声薄膜的宽度不同,且均不同于所述可变声阻抗薄膜的宽度。The implantable cardiac pacemaker of claim 6, wherein the width of the first sound-absorbing film is different from the width of the second sound-absorbing film, and both are different from the variable acoustic impedance film. width.
  8. 如权利要求2所述的植入式心脏起搏器,其特征在于,所述信号处理模块通过使所述可变声阻抗薄膜通电或断电来改变所述可变声阻抗模块的声阻抗。The implantable cardiac pacemaker of claim 2, wherein the signal processing module changes the acoustic impedance of the variable acoustic impedance module by energizing or de-energizing the variable acoustic impedance film.
  9. 如权利要求1所述的植入式心脏起搏器,其特征在于,所述信号处理模块包括处理器、ADC单元和DAC单元;所述ADC单元用于将所述可变声阻抗模块发送的电信号转换为数字信号,并发送至所述处理器;所述DAC单元用于将所述处理器发送的用于改变声阻抗的信号转换为模拟信号,并发送给所述可变声阻抗模块,所述可变声阻抗模块根据所述DAC单元发送的模拟信号调整声阻抗。The implantable cardiac pacemaker of claim 1, wherein the signal processing module includes a processor, an ADC unit and a DAC unit; the ADC unit is used to convert the electrical signal sent by the variable acoustic impedance module. The signal is converted into a digital signal and sent to the processor; the DAC unit is used to convert the signal sent by the processor for changing the acoustic impedance into an analog signal and sends it to the variable acoustic impedance module, so The variable acoustic impedance module adjusts the acoustic impedance according to the analog signal sent by the DAC unit.
  10. 如权利要求1所述的植入式心脏起搏器,其特征在于,所述植入式心脏起搏器为无导线起搏器。The implantable cardiac pacemaker according to claim 1, wherein the implantable cardiac pacemaker is a leadless pacemaker.
  11. 一种程控装置,其特征在于,包括程控仪主机和超声程控头;所述超声程控头用于发送超声信号和感知超声反射信号;所述程控仪主机通过所述超声程控头发出的超声信号向植入式心脏起搏器传输数据,并通过所述超声程控头感知的超声反射信号获得所述植入式心脏起搏器的声阻抗状态,根据所述声阻抗状态的变化获取所述植入式心脏起搏器的数据。A programmable control device, characterized in that it includes a programmable instrument host and an ultrasonic programmable control head; the ultrasonic programmable control head is used to send ultrasonic signals and sense ultrasonic reflection signals; the programmable instrument host emits ultrasonic signals through the ultrasonic programmable control head to The implanted cardiac pacemaker transmits data, and obtains the acoustic impedance state of the implanted cardiac pacemaker through the ultrasonic reflection signal sensed by the ultrasonic programmable control head, and obtains the implanted cardiac pacemaker according to changes in the acoustic impedance state. pacemaker data.
  12. 一种心脏起搏系统,其特征在于,包括如权利要求1至10任一项所述的植入式心脏起搏器和如权利要求11所述的程控装置。 A cardiac pacing system, characterized by comprising the implantable cardiac pacemaker according to any one of claims 1 to 10 and the programmable device according to claim 11.
PCT/CN2023/083250 2022-04-01 2023-03-23 Implantable cardiac pacemaker, program control apparatus, and cardiac pacing system WO2023185606A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202210349277.XA CN116920278A (en) 2022-04-01 2022-04-01 Implantable cardiac pacemaker, program control device and cardiac pacing system
CN202210349277.X 2022-04-01

Publications (1)

Publication Number Publication Date
WO2023185606A1 true WO2023185606A1 (en) 2023-10-05

Family

ID=88199191

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/083250 WO2023185606A1 (en) 2022-04-01 2023-03-23 Implantable cardiac pacemaker, program control apparatus, and cardiac pacing system

Country Status (2)

Country Link
CN (1) CN116920278A (en)
WO (1) WO2023185606A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100010354A1 (en) * 2008-07-09 2010-01-14 Olaf Skerl Implantable ultrasonic measurement arrangement
US20120203306A1 (en) * 2005-09-10 2012-08-09 Artann Laboratories, Inc. Systems for remote generation of electrical signal in tissue based on time-reversal acoustics
CN108837305A (en) * 2018-05-15 2018-11-20 清华大学 Flexible pacemaker and bioelectricity monitoring method based on flexible pacemaker
CN109982629A (en) * 2016-07-07 2019-07-05 加州大学评议会 Use the implantation material of ultrasonic stimulation tissue
CN112022145A (en) * 2020-09-30 2020-12-04 苏州无双医疗设备有限公司 External defibrillation equipment and combined system thereof
CN113613708A (en) * 2019-01-23 2021-11-05 香港理工大学 Method of targeted energy delivery on an implantable device using one or more ultrasound transducers

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120203306A1 (en) * 2005-09-10 2012-08-09 Artann Laboratories, Inc. Systems for remote generation of electrical signal in tissue based on time-reversal acoustics
US20100010354A1 (en) * 2008-07-09 2010-01-14 Olaf Skerl Implantable ultrasonic measurement arrangement
CN109982629A (en) * 2016-07-07 2019-07-05 加州大学评议会 Use the implantation material of ultrasonic stimulation tissue
CN108837305A (en) * 2018-05-15 2018-11-20 清华大学 Flexible pacemaker and bioelectricity monitoring method based on flexible pacemaker
CN113613708A (en) * 2019-01-23 2021-11-05 香港理工大学 Method of targeted energy delivery on an implantable device using one or more ultrasound transducers
CN112022145A (en) * 2020-09-30 2020-12-04 苏州无双医疗设备有限公司 External defibrillation equipment and combined system thereof

Also Published As

Publication number Publication date
CN116920278A (en) 2023-10-24

Similar Documents

Publication Publication Date Title
US9731141B2 (en) Multi-element acoustic recharging system
US9095284B2 (en) Distance measurement using implantable acoustic transducers
JP4931809B2 (en) Acoustic communication system for implantable medical devices
US7570998B2 (en) Acoustic communication transducer in implantable medical device header
US7580750B2 (en) Implantable medical device with integrated acoustic transducer
JP5155311B2 (en) Ultrasonic transmitting / receiving transducer housed in header of implantable medical device
EP3997776A1 (en) Systems, devices, and methods for establishing a wireless link
US20090201148A1 (en) Systems and methods for controlling wireless signal transfers between ultrasound-enabled medical devices
JPH01195869A (en) Cardiac pacemaker
WO2012154599A2 (en) Intelligent self-organizing electrode stimulation delivery system
JP2009544366A (en) Ultrasonic transducer for use in medical devices with implanted metal cavities
US20180256905A1 (en) Multi-Site Ultrasonic Wireless Pacemaker-Defibrillator
US20110004075A1 (en) Vascular pressure sensor with electrocardiogram electrodes
CN111032148B (en) Implantable medical device with pressure sensor
WO2023185606A1 (en) Implantable cardiac pacemaker, program control apparatus, and cardiac pacing system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23777976

Country of ref document: EP

Kind code of ref document: A1